Leprosy - Current aspects;Aktuelle Aspekte der Lepra

Hautarzt

Volumn 48, Issue 5, 1997, Pages 297-302

  Sticht Groh, V ^a   Bretzel, G ^a  

^a Klinikum der Ludwig Maximilians Universität München   (Germany)

Author keywords

clinical features; diagnosis; leprosy; reactions; treatment

Indexed keywords

CELLULAR IMMUNITY; CORRELATION FUNCTION; DISEASE CLASSIFICATION; DISEASE TRANSMISSION; HOST RESISTANCE; HUMAN; LEPROSY; MYCOBACTERIUM LEPRAE; REVIEW; T LYMPHOCYTE;

ANIMALS; CD4-CD8 RATIO; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; LEPROSTATIC AGENTS; LEPROSY; LEPROSY, LEPROMATOUS; LEPROSY, TUBERCULOID;

EID: 0030994433     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050586     Document Type: Review

References (32)

1. Bechelli LM, Martinez Dominguez M (1966) The leprosy problem in the world. Bull WHO 34:811-826
2. Clark-Curtiss JE, Jacobs WR, Doherty MA, Rotchie LR, Curtiss R (1985) Molecular analysis of DNA and construction of genomic libraries of M. leprae. J Bacteriol 161:1093-1102
3. Davey TF, Rees RJW (1974) The nasal discharge in leprosy: clinical and bacteriological aspects. Lepr Rev 45:121-125
4. Desikan KV (1995) Toward elimination of leprosy. Some constrains and pitfalls. ILA Forum 2:4-8
5. Depasquale G (1986) The Malta experience, lsoprodianrifampicin combination treatment for leprosy. Lep Rev 57 [Suppl 3]:29-37
6. Freerksen E, Seydel JK (1992) Critical comments on the treatment of leprosy and other mycobacterial infections with clofazimine. Arzneimittelforsch/Drug Res 42:1243-1245
7. Grosset JH (1994) Progress in the chemotherapy of leprosy. Int J Lepr 62:268-277
8. Htoon MT, Bertolli J, Koshaih LD (1994) Leprosy. In:Jamieson DT (ed) Disease control priorities in developing countries. Oxford University, Oxford, pp 261-280
9. Ji B,Grosset JH (1991) Ofloxacin treatment of leprosy. Acta Leprol 7:321-326
10. Jopling WH (1986) A report on two follow-up investigations of the Malta-Project. Lepr Rev 57 [Suppl 3]:47-52
11. Kempsell KE, Yuan-en J, Estrada G, Colston, MJ, Cox MA (1992) The nucleotide sequence of the promoter, 16S rRNA and spacer region of the ribosomal RNA operon of Mycobacterium tuberculosis and comparison with Mycobacterium leprae precursor RNA. J Gen Microbiol 138:1717-1727
12. Klauß V (1993) Tropische Ophthalmologie. In: Lang W (Hrsg) Tropenmedizin in Klinik und Praxis. Thieme, Stuttgart New York
13. Lechat MF, Declercq EE (1994) Control programs in leprosy. In:Hastings RC (ed) Leprosy. Churchill Livingstone, New York, pp 367-381
14. Leiker DL (1986) On the epidemiology of leprosy in Malta. Lepr Rev 57 [Suppl 3]:38-41
15. Leiker DL (1986) First assessment of the Malta leprosy eradication project. Lepr Rev 57 [Suppl 3]:42-46
16. Leonard G, Sangare A, Verdier M (1990) Prevalence of HIV infection among patients in African countries and Yemen. J Acquired Imm Defic Syndrome 3:1109-1111
17. Meyers WM (1992) Leprosy. New Dev Dermatopathol 10 73-96
18. Modlin RL, Mehra V, Wong L (1986) Suppressor T lymphocytes from lepromatous skin lesions. J Immunol 137:2831-2834
19. Modlin RL, Rea TH (1994) Immunopathology of leprosy. In. Hastings RC (ed) Leprosy.Churchill Livingstone, New York, pp 225-234
20. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cells done. J Immunol 36:2348-2357
21. Mustafa AS, Gill HK, Nerland A, Britton WJ, Mehra V, Bloom BR, Young RA, Godal R (1986) Human T-cell clones recognize a major M. leprae protein antigen expressed in E. coli. Nature 319:63-65
22. Nordeen SK (1994) The epidemiology of leprosy, In:Hastings RC (ed) Leprosy. Churchill Livingstone, New York, pp 29-45
23. Rees RWS, McDougall AC (1977) Airborne infection with Mycobacterium leprae in mice. J Med Microbiol 10:63-65
24. Ridley DS, Jopling WH (1966) Classification of leprosy according to immunity: a five-group system. Int J Lepr 34:255-260
25. Sampaio EP, Moreira AL, Sarno EN, Malta AM, Kaplan G (1992) Prolonged treatment with recombinant interferon gamma induces erythema nodosum in lepromatos leprosy patients. J Exp Med 175:1729-1737
26. Schadenwaldt H (1969) Zur Geschichte der Lepra. Hautarzt 20:124-130
27. Schnurr ED, Malo D, Radzioch D (1969) Genetic control of innate resistance to mycobacterial infections, Immunoparasitol Today 12:42-46
28. Shepard CC (1960) The experimental disease that follows the injection of human leprosy bacilli into footpads of mice. J Exp Med 112:445-454
29. Stach JL, Stobel M, Fumvux F, Bach JP (1982) Defect in the generation of cytotoxic T cells in lepromatous leprosy. Clin Exp Immunol 71:235-240
30. Stindl E, Kober H (1964) Hoffnung der Ausgestoßenen. S 55-56
31. Who (1994) Chemotherapy of Leprosy. WHO Technical Report Series 847, WHO, Geneva
32. Zastrow KD, Schonberg T (1993) Lepraeinschleppungen nach Deutschland 1981-1992. Gesundh Wes 55:414-417